Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Sample of patents with BPC 157 utilization. Download Scientific Diagram Safety advisory Understanding your responsibilities when importing, compounding and supplying unapproved peptide products We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products TGA warning on the risks of importing unapproved peptide products We are warning consumers about the risks of importing and using unapproved peptide products that are promoted online. The TGA continues to BPC 157 For Knee Pain: Early Reported Outcomes, A report on intra articular BPC 157 for knee pain described high rates of improvement: ~92% with BPC 157 alone, ~75% when combined with thymosin beta 4,